Back to Search
Start Over
Reply to Chhablani
- Publication Year :
- 2010
- Publisher :
- Nature Publishing Group, 2010.
-
Abstract
- Sir, We thank Dr Chhablani1 for his interest in our article2; we evaluated diffuse diabetic macular oedema and obtained good functional and anatomic results during a follow-up of 12 months after treatment with intravitreal bevacizumab, when compared with the combination of intravitreal triamcinolone and laser photocoagulation. We agree that intravitreal bevacizumab lacks in large randomized controlled trials and could be used in case of gross macular oedema in order to reduce macular thickening, followed by laser photocoagulation. The latter remains indeed the gold standard for diabetic macular oedema.
- Subjects :
- medicine.medical_specialty
Intravitreal triamcinolone
genetic structures
business.industry
Macular oedema
eye diseases
law.invention
Ophthalmology
Randomized controlled trial
Diabetic macular oedema
law
Correspondence
medicine
sense organs
Macular thickening
Intravitreal bevacizumab
business
After treatment
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1be2730011cd41257438183ecb785806